Announced
Completed
Synopsis
Boston Scientific, a global medical technology firm, completed the acquisition of Preventice Solutions, a provider of mobile cardiac health solutions and services, for $1.2bn, comprising of an upfront cash payment of $925m, and an additional $300m in a potential commercial milestone payment. "We are confident that by adding the broad technology portfolio and expertise of Preventice, our combined teams can continue to deliver rapid growth in these highly-attractive markets while also establishing an important adjacency to our core cardiac rhythm management and electrophysiology businesses," Scott Olson, Boston Scientific Senior Vice President and President of Rhythm Management.
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.